Fmoc-Asp-NH2 - CAS 200335-40-6

Fmoc-Asp-NH2 - CAS 200335-40-6 Catalog number: BADC-01030

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Fmoc-Asp-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Category
ADCs Linker
Product Name
Fmoc-Asp-NH2
CAS
200335-40-6
Catalog Number
BADC-01030
Molecular Formula
C19H18N2O5
Molecular Weight
354.36
Fmoc-Asp-NH2

Ordering Information

Catalog Number Size Price Quantity
BADC-01030 -- $--
Inquiry
Description
Fmoc-Asp-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Synonyms
Fmoc-L-Isoasparagine; Fmoc-Isoasn-OH; Butanoic acid, 4-amino-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4-oxo-, (3S)-
IUPAC Name
(3S)-4-amino-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC(CC(=O)O)C(=O)N
InChI
InChI=1S/C19H18N2O5/c20-18(24)16(9-17(22)23)21-19(25)26-10-15-13-7-3-1-5-11(13)12-6-2-4-8-14(12)15/h1-8,15-16H,9-10H2,(H2,20,24)(H,21,25)(H,22,23)/t16-/m0/s1
InChIKey
VHRMWRHTRSQVJJ-INIZCTEOSA-N
Density
1.362 g/cm3
Solubility
10 mm in DMSO
Melting Point
185-190 °C
Flash Point
354.2°C
Index Of Refraction
1.626
LogP
2.94490
PSA
118.72000
Vapor Pressure
1.97E-18mmHg at 25°C
Biological Activity
Fmoc-Asp-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). In Vitro: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
Appearance
White powder
Purity
≥98.0%
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature
Storage
-20°C
Boiling Point
662.1 °C at 760 mmHg

Fmoc-Asp-NH2, known as Fmoc-Aspartic Acid Amide, is a critical building block in the synthesis of antibody-drug conjugates (ADCs). ADCs represent a revolutionary class of biopharmaceuticals designed for targeted cancer therapy. They combine the high specificity of monoclonal antibodies with the potent cytotoxicity of small molecule drugs. The linker, such as Fmoc-Asp-NH2, plays a crucial role in connecting these two components securely. By ensuring stability in circulation and enabling release of the drug payload within cancer cells, Fmoc-Asp-NH2 effectively enhances the efficacy and safety profile of ADCs compared to traditional chemotherapy.

The versatile chemistry of Fmoc-Asp-NH2 contributes to its widespread application in drug discovery and development. Fmoc (9-fluorenylmethoxycarbonyl) is a protecting group that allows for sequential addition of amino acids in peptide synthesis, which is integral to forming peptide linkers in ADCs. Aspartic acid provides a site for further functionalization and attachment to either the antibody or drug moiety. This modularity facilitates the design of ADCs with tailored properties, such as optimized pharmacokinetics and controlled drug release profiles. Researchers can thus fine-tune ADCs to maximize tumor eradication while minimizing off-target effects.

Fmoc-Asp-NH2’s cleavable nature is particularly beneficial in ADC technology. Cleavable linkers are designed to remain stable in the bloodstream but degrade in response to specific stimuli within the tumor microenvironment. This feature is crucial as it allows the release of the cytotoxic drug precisely at the site of the tumor, minimizing damage to healthy tissues. Enzymatic cleavage is a common strategy, where linkers like Fmoc-Asp-NH2 are sensitive to specific enzymes overexpressed in cancer cells. This ability to engineer selective drug release represents a significant advancement in personalized medicine and targeted therapy.

In the rapidly evolving landscape of oncology, Fmoc-Asp-NH2 is pivotal for the development of next-generation ADCs with enhanced therapeutic windows. Pharmaceutical researchers leverage its properties to overcome challenges such as drug resistance and heterogeneity of cancer cells. Combining advanced molecular biology techniques with the strategic use of linkers like Fmoc-Asp-NH2 allows for the production of more sophisticated ADCs, potentially leading to better patient outcomes. The strategic manipulation of ADC components can also lead to dual-targeting strategies or the incorporation of immune-stimulatory agents, broadening the scope of ADC applications.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Historical Records: Fmoc-Asp-NH2
Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Inquiry Basket